Adverse Events After the Third Dose of COVID-19 Vaccine: A Case Study of Healthcare Workers at Buntharik Hospital, Thailand

Name: Kopkan Choopan

Address: 333 Moo1, Thasud, Muang, Chiang Rai 57100

Organization : School of Health Science, Mae Fah Luang University

Email : library@mfu.ac.th

Name: Thatsawatpagorn Salase

keyword: Adverse events following immunization

ThaSH: Health Science

; COVID-19 vaccines

ThaSH: Alternative medicine

; Risk factors, Thailand

ThaSH: COVID-19 vaccines

ThaSH: Diseases -- Risk factors

Abstract: Introduction: COVID-19 vaccine is currently being developed then the information regarding the unfavorable adverse events of vaccines is not clearly known. Objective: The purpose of this study was to estimate the prevalence of and to determine factor adverse events after receiving the third dose of COVID-19 vaccine among healthcare workers who were working at Buntharik hospital in Ubon Ratchathani Province. Methods: A cross-sectional study was conducted for data collection among healthcare workers who received the third dose of the AstraZeneca vaccine in July 2021. Data were collected from LINE group which was specific design to monitor the adverse events following immunization (AEFI) among people who received the 3 rddose of the COVID-19 vaccine. Independent t-test and logistic regression were used to detect mean differences and factors associated between variables at the significance level of =0.05. Results: A total of 74 participants were recruited into the study; 21.6% of vaccine-related adverse events without any severe symptoms were reported. More than half were females (62.2%), an average age was 37.2±10.5 years, and 18.8% were presented with chronic illness at the time of immunization. Fever was reported as the highest adverse event after getting the 3rddose (81.3%), myalgia (75.0%), and pain and edema at the injection site (56.3%). Two variables were found to be associated with having adverse events after getting the 3rddose of COVID-19 vaccination. Those who had body mass index (BMI) 23 kg/m2 had a 5.3 time (95%CI=1.34-20.95) greater chance to have adverse events than those who were normal BMI. Those who received the 3rddose after the 2ndfor 56 days had a 3.4 time (95%CI=1.02-11.49) greater chance to have an adverse event than those who received their 3rddose after 28-41days of the 2nddose. Conclusion: Individuals’ BMI and time interval between the 2 nddose and 3 rddose are presented as factors associated with presenting adverse event who receive COVID-19 vaccine. All people who are planning to receive COVID-19 vaccine should be informed in concerning their BMI and time between the doses to avoid adverse events.

Mae Fah Luang University. Learning Resources and Educational Media Center

Address: CHIANG RAI

Email: library@mfu.ac.th

Modified: 2023-01-13

Issued: 2023-01-13

บทความ/Article

application/pdf

Journal of Health Science and Alternative Medicine (2022) Vol.4 (3): 1-5

eng

©copyrights Mae Fah Luang University

ลำดับที่.	ชื่อแฟ้มข้อมูล	ขนาดแฟ้มข้อมูล	จำนวนเข้าถึง	วัน-เวลาเข้าถึงล่าสุด
1	2022-v04-no03-p1-5.pdf	260.25 KB	2	2023-06-14 19:34:25

ใช้เวลา

0.034417 วินาที